Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.010
-0.070 (-1.72%)
At close: Apr 2, 2026, 4:00 PM EDT
4.020
+0.010 (0.25%)
After-hours: Apr 2, 2026, 4:58 PM EDT
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $94.06 million as of April 2, 2026. Its market cap has decreased by -12.80% in one year.
Market Cap
94.06M
Enterprise Value
47.24M
1-Year Change
-12.80%
Ranking
Category
Stock Price
$4.01
Market Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $94.06M, an increase of 694.64%. That is a compound annual growth rate of 88.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 94.06M | -22.49% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 99.90M |
| Turn Therapeutics | 98.64M |
| Spruce Biosciences | 96.72M |
| Seer, Inc. | 95.92M |
| Verrica Pharmaceuticals | 93.97M |
| Aardvark Therapeutics | 93.81M |
| Q32 Bio | 93.34M |
| Pyxis Oncology | 92.99M |